1 Us-china Biomedical Technology, Inc. Receivables Turnover Ratio (CLDS), from the first quarter 2020 to the first quarter 2019 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Competitors, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Us-china Biomedical Technology, Inc. (CLDS)

Sector • Services Industry • Advertising

Industry • Advertising

Sector • Services

Us-china Biomedical Technology Accounts Receivables Turnover Ratio from the first quarter 2020 to the first quarter 2019

Quarterly Results, Trends, Rankings, Statistics

According to Us-china Biomedical Technology, Inc. Balance Sheet, in the first quarter 2020, company has not reported any Accounts receivable.
See Us-china Biomedical Technology, Inc. Balance Sheet

If we take a look into Services sector Us-china Biomedical Technology, Inc. achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Us-china Biomedical Technology, Inc. Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CLDS Receivables Turnover Ratio	(May 31 2019) I. Quarter	(Feb 28 2019) IV. Quarter	(Nov 30 2018) III. Quarter	(Aug 31 2018) II. Quarter	(May 31 2018) I. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	-	-	-	-	-
CLDS's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Advertising Industry	#
Services Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

CLDS Company Profile • Back to CLDS Efficiency Comparisons • Compare CLDS Receivables Turnover Ratio to its Competitors

Financial Statements
Us-china Biomedical Technology's Accounts Receivable	$ 0 Millions	Visit CLDS's Balance sheet
Us-china Biomedical Technology's Sales TTM	$ 0 Millions	Visit CLDS's Income Statement
Sources of CLDS's Revenues		Visit CLDS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Advertising Industry Accounts Receivable Turnover Trends and Statistics
Services Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CLDS's Receivable Turnover Ratio versus Advertising Industry, Services Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CLDS's Growth Rates	CLDS's Roa	CLDS's Inventory Turnover Ratio	CLDS's Dividend Comparisons
CLDS's Profitability Ratios	CLDS's Roi	CLDS's Asset Turnover Ratio	CLDS's Dividend Growth
CLDS's Valuation Ratios	CLDS's Roe	CLDS's Financial Strength Ratios	CLDS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending May 31 2019, within Services Sector

Receivable Turnover Ratio

Revenues for 12 Months ending May 31 2019

Receivable at quarter ending May 31 2019

Date modified: 2026-09-08T15:09:36+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.